Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World

Clinical trial NCT04515186 · COMPLETED

Trial details

NCT number: NCT04515186
Sponsor: Drugs for Neglected Diseases
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cutaneous Leishmaniases

Start date: 2021-01-26
Primary completion: 2023-11-10
Enrollment: 184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.